Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Apply
Venetoclax & Obinutuzumab
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step